Drugs / Staphylococcus aureus 4-antigen vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02492958 | Jun 2015 → Sep 2016 | staphylococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Staphylococcus aureus 4-antigen vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02492958 ↗ |
| Modality | Vaccine | “4-antigen Vaccine” NCT02492958 ↗ |
| Route | Intramuscular | “into the deltoid muscle” NCT02492958 ↗ |